Ono, Dainippon Sumitomo File For Approval Of Peripheral Circulation Drug Limaprost Alfadex In Japan
This article was originally published in PharmAsia News
Executive Summary
Ono Pharmaceuticals and Dainippon Pharmaceuticals in Japan have both filed for the approval of a more stable formulation of the peripheral circulatory disorder drug limaprost alfadex.